ginkgo biloba

Botanicalexperimental

Ginkgo biloba, commonly known as ginkgo, also known as the maidenhair tree, and often misspelled "gingko" is a species of gymnosperm tree native to East Asia. It is the last living species in the order Ginkgoales, which first appeared over 290 million years ago. Fossils similar to the living species, belonging to the genus Ginkgo, extend back to the Middle Jurassic epoch approximately 170 million years ago. The tree was cultivated early in human history, remains commonly planted, and is widely regarded as a living fossil. — Wikipedia

Clinical trial activity

27 trials · 29 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
3
Phase 3
4
Phase 4
6

Earliest trial started Oct 1, 2004 (NCT00164749)

Timeline

2000s

  1. Jan 1, 2004

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2017

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • ginkgo extract

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07236645Phase 2Nov 20, 2025Jiao Tong University
NCT07220538Phase 4Oct 30, 2025Capital Medical University, Schwabe
NCT06771128N/ANov 1, 2024Menoufia University
NCT06495476Phase 4Sep 1, 2024Capital Medical University
NCT07287852Phase 2Aug 20, 2024Hebrew University
NCT06772584N/AJan 1, 2024Menoufia University
NCT06140888N/AJan 1, 2024Jinlin University
NCT06124703N/ANov 10, 2023Fudan University
NCT05531942Phase 2/Phase 3 (Phase 3)Oct 1, 2022Shanghai University of Traditional Chinese Medicine
NCT05591144N/AJul 1, 2022Fudan University
NCT06403787Phase 2/Phase 3 (Phase 3)May 1, 2022University of Guadalajara
NCT05398874N/ANov 1, 2021Kufa University
NCT04846179Phase 4May 31, 2021Government of Canada
NCT05663307Phase 2/Phase 3 (Phase 3)Jan 1, 2021Shanghai University of Traditional Chinese Medicine
NCT04529148Phase 4Sep 20, 2020Guangzhou University, WanBangDe Pharmaceutical Group Co.,Ltd.
NCT04492241N/AAug 1, 2020Beijing Stroke Association, Capital Medical University
NCT04192656Phase 4Nov 1, 2019Tsinghua University
NCT04121728N/ASep 9, 2019University of Lausanne
NCT03772418Phase 1May 18, 2018Al Azhar University, Qassim University
NCT03483779Phase 4Apr 25, 2018China Academy of Chinese Medical Sciences, WanBangDe Pharmaceutical Group Co.,Ltd.
Showing 20 of 27 trials
Page 1 / 2

Organizations

Research & Development (29)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Capital Medical UniversityAcademic/Hospital3222020
Fudan UniversityAcademic/Hospital2212022
Jiao Tong UniversityAcademic/Hospital2222017
Menoufia UniversityAcademic/Hospital2212024
Peking UniversityAcademic/Hospital2212013
Shanghai University of Traditional Chinese MedicineAcademic/Hospital2212021
WanBangDe Pharmaceutical Group Co.,Ltd.For profit2112018
Al Azhar UniversityAcademic/Hospital1112018
Beijing Stroke AssociationAcademic/Hospital1012020
BUPA UK FoundationAcademic/Hospital1012004
China Academy of Chinese Medical SciencesAcademic/Hospital1112018
Chinese Academy of Medical SciencesAcademic/Hospital1012017
Chinese University of Hong KongAcademic/Hospital1112004
Government of CanadaGovernment1112021
Guangzhou UniversityAcademic/Hospital1012020
Hebrew UniversityAcademic/Hospital1112024
Jiangsu Kanion Pharmaceutical Co., LtdFor profit1012017
Jinlin UniversityAcademic/Hospital1112024
Kufa UniversityAcademic/Hospital1112021
Kwong Wah HospitalAcademic/Hospital1012004
29 organizations
Page 1 / 2